Kevin D's most recent trade in Definitive Healthcare Corp - Ordinary Shares - Class A was a trade of 37,593 Class A Common Stock done at an average price of $1.1 . Disclosure was reported to the exchange on April 1, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Definitive Healthcare Corp (Class A) | Kevin D. Coop | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.09 per share. | 01 Apr 2026 | 37,593 | 5,078,872 | - | 1.1 | 40,976 | Class A Common Stock |
| Hagerty Inc (Class A) | Kevin M. Delaney | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2026 | 17,614 | 108,411 | - | 0 | Class A Common Stock | |
| Hagerty Inc (Class A) | Kevin M. Delaney | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.66 per share. | 01 Apr 2026 | 8,456 | 99,955 | - | 10.7 | 90,141 | Class A Common Stock |
| First Merchants Corp | Kevin D. Johnson | Director | Grant, award, or other acquisition of securities at price $ 38.73 per share. | 31 Mar 2026 | 564 | 8,983 (0%) | 0% | 38.7 | 21,844 | Common |
| Republic Bancorp Inc KY | Kevin D. Sipes | EVP & CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 71.02 per share. | 31 Mar 2026 | 65 | 75,347 (0%) | 0% | 71.0 | 4,616 | Class A Common Stock |
| PPG Industries | Kevin D. Braun | Sr VP, Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2026 | 7 | 861 | - | - | Phantom Stock Units | |
| Renasant Corp | Kevin D. Chapman | President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.39 per share. | 19 Mar 2026 | 7,372 | 201,882 (0%) | 0% | 34.4 | 253,523 | Common Stock |
| Renasant Corp | Kevin D. Chapman | President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Mar 2026 | 3,816 | 209,254 (0%) | 0% | 0 | Common Stock | |
| Imax Corp | Kevin G. Douglas | Director, Ten Percent Owner, 13(d)(3) group | Sale of securities on an exchange or to another person at price $ 37.82 per share. | 16 Mar 2026 | 330,200 | 3,657,450 (5%) | 0% | 37.8 | 12,488,164 | Common Stock |
| Imax Corp | Kevin G. Douglas | Director, Ten Percent Owner, 13(d)(3) group | Sale of securities on an exchange or to another person at price $ 37.82 per share. | 16 Mar 2026 | 62,600 | 1,301,045 (2%) | 0% | 37.8 | 2,367,532 | Common Stock |
| Imax Corp | Kevin G. Douglas | Director, Ten Percent Owner, 13(d)(3) group | Sale of securities on an exchange or to another person at price $ 37.82 per share. | 16 Mar 2026 | 43,800 | 602,311 (0%) | 0% | 37.8 | 1,656,516 | Common Stock |
| Imax Corp | Kevin G. Douglas | Director, Ten Percent Owner, 13(d)(3) group | Sale of securities on an exchange or to another person at price $ 37.82 per share. | 16 Mar 2026 | 43,800 | 602,310 (0%) | 0% | 37.8 | 1,656,516 | Common Stock |
| Imax Corp | Kevin G. Douglas | Director, Ten Percent Owner, 13(d)(3) group | Sale of securities on an exchange or to another person at price $ 37.82 per share. | 16 Mar 2026 | 43,800 | 602,310 (0%) | 0% | 37.8 | 1,656,516 | Common Stock |
| Imax Corp | Kevin G. Douglas | Director, Ten Percent Owner, 13(d)(3) group | Sale of securities on an exchange or to another person at price $ 37.82 per share. | 16 Mar 2026 | 43,800 | 602,310 (0%) | 0% | 37.8 | 1,656,516 | Common Stock |
| PPG Industries | Kevin D. Braun | Sr VP, Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2026 | 1 | 854 | - | - | Phantom Stock Units | |
| Cerus Corp | Kevin D. Green | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 1.66 per share. | 12 Mar 2026 | 127,544 | 1,040,551 (0%) | 0% | 1.7 | 211,366 | Common Stock |
| Casella Waste Systems Inc (Class A) | Kevin J. Drohan | VP & CHIEF ACCOUNTING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2026 | 551 | 8,013 (0%) | 0% | 0 | Class A Common Stock | |
| Casella Waste Systems Inc (Class A) | Kevin J. Drohan | VP & CHIEF ACCOUNTING OFFICER | Sale of securities on an exchange or to another person at price $ 87.73 per share. | 12 Mar 2026 | 85 | 7,873 (0%) | 0% | 87.7 | 7,457 | Class A Common Stock |
| Casella Waste Systems Inc (Class A) | Kevin J. Drohan | VP & CHIEF ACCOUNTING OFFICER | Sale of securities on an exchange or to another person at price $ 89.53 per share. | 12 Mar 2026 | 55 | 7,958 (0%) | 0% | 89.5 | 4,924 | Class A Common Stock |
| PPG Industries | Kevin D. Braun | Sr VP, Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2026 | 8 | 853 | - | - | Phantom Stock Units | |
| Tredegar Corp | Kevin C. Donnelly | See Remarks | Grant, award, or other acquisition of securities at price $ 7.74 per share. | 11 Mar 2026 | 31,078 | 179,981 (0%) | 0% | 7.7 | 240,544 | Tredegar Common Stock |
| Cerus Corp | Kevin D. Green | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2026 | 63,854 | 1,251,116 (0%) | 0% | 0 | Common Stock | |
| Cerus Corp | Kevin D. Green | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 2.06 per share. | 05 Mar 2026 | 55,225 | 1,195,891 (0%) | 0% | 2.1 | 113,902 | Common Stock |
| Cerus Corp | Kevin D. Green | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 2.01 per share. | 05 Mar 2026 | 27,796 | 1,168,095 (0%) | 0% | 2.0 | 55,745 | Common Stock |
| Biofrontera Inc | Kevin D. Weber | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2026 | 20,000 | 20,000 | - | - | Employee stock option (right to buy) | |
| Middlefield Banc Corp | Kevin A. DiGeronimo | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Mar 2026 | 5,071 | 0 (0%) | 0% | - | Common Stock | |
| Casella Waste Systems Inc (Class A) | Kevin J. Drohan | VP & CHIEF ACCOUNTING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2026 | 2,452 | 8,137 (0%) | 0% | 0 | Class A Common Stock | |
| Casella Waste Systems Inc (Class A) | Kevin J. Drohan | VP & CHIEF ACCOUNTING OFFICER | Sale of securities on an exchange or to another person at price $ 92.61 per share. | 26 Feb 2026 | 675 | 7,462 (0%) | 0% | 92.6 | 62,512 | Class A Common Stock |
| Middlefield Banc Corp | Kevin A. DiGeronimo | Director | Grant, award, or other acquisition of securities at price $ 35.18 per share. | 23 Feb 2026 | 405 | 5,071 (0%) | 0% | 35.2 | 14,248 | Common Stock |
| Pulse Biosciences Inc | Kevin P. Danahy | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.53 per share. | 18 Feb 2026 | 5,000 | 48,298 (0%) | 0% | 1.5 | 7,650 | Common Stock |
| Pulse Biosciences Inc | Kevin P. Danahy | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2026 | 5,000 | 300,000 | - | - | Stock Option (right to buy) | |
| Pulse Biosciences Inc | Kevin P. Danahy | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 23.64 per share. | 18 Feb 2026 | 5,000 | 43,298 (0%) | 0% | 23.6 | 118,200 | Common Stock |
| Pulse Biosciences Inc | Kevin P. Danahy | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2026 | 20,000 | 305,000 | - | - | Stock Option (right to buy) | |
| Pulse Biosciences Inc | Kevin P. Danahy | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2026 | 20,000 | 325,000 | - | - | Stock Option (right to buy) | |
| Pulse Biosciences Inc | Kevin P. Danahy | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.53 per share. | 12 Feb 2026 | 20,000 | 63,298 (0%) | 0% | 1.5 | 30,600 | Common Stock |
| Pulse Biosciences Inc | Kevin P. Danahy | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 23.37 per share. | 12 Feb 2026 | 20,000 | 43,298 (0%) | 0% | 23.4 | 467,400 | Common Stock |
| Pulse Biosciences Inc | Kevin P. Danahy | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.53 per share. | 12 Feb 2026 | 20,000 | 63,298 (0%) | 0% | 1.5 | 30,600 | Common Stock |
| Pulse Biosciences Inc | Kevin P. Danahy | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 23.53 per share. | 12 Feb 2026 | 20,000 | 43,298 (0%) | 0% | 23.5 | 470,600 | Common Stock |
| Pulse Biosciences Inc | Kevin P. Danahy | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.53 per share. | 12 Feb 2026 | 20,000 | 63,298 (0%) | 0% | 1.5 | 30,600 | Common Stock |
| Pulse Biosciences Inc | Kevin P. Danahy | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 23.63 per share. | 12 Feb 2026 | 20,000 | 43,298 (0%) | 0% | 23.6 | 472,600 | Common Stock |
| Pulse Biosciences Inc | Kevin P. Danahy | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2026 | 20,000 | 345,000 | - | - | Stock Option (right to buy) | |
| RTX | Kevin G. DaSilva | Senior VP and Treasurer | Sale of securities on an exchange or to another person at price $ 201.31 per share. | 11 Feb 2026 | 7,951 | 27,102 (0%) | 0% | 201.3 | 1,600,621 | Common Stock |
| RTX | Kevin G. DaSilva | Senior VP and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2026 | 3,100 | 3,100 | - | - | Stock Appreciation Right | |
| RTX | Kevin G. DaSilva | Senior VP and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2026 | 2,485 | 10,355 | - | - | Restricted Stock Units | |
| RTX | Kevin G. DaSilva | Senior VP and Treasurer | Sale of securities on an exchange or to another person at price $ 200.67 per share. | 11 Feb 2026 | 185 | 35,053 (0%) | 0% | 200.7 | 37,124 | Common Stock |
| Pulse Biosciences Inc | Kevin P. Danahy | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2026 | 20,000 | 365,000 | - | - | Stock Option (right to buy) | |
| Pulse Biosciences Inc | Kevin P. Danahy | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2026 | 20,000 | 405,000 | - | - | Stock Option (right to buy) | |
| Pulse Biosciences Inc | Kevin P. Danahy | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2026 | 20,000 | 385,000 | - | - | Stock Option (right to buy) | |
| Pulse Biosciences Inc | Kevin P. Danahy | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.53 per share. | 09 Feb 2026 | 20,000 | 63,298 (0%) | 0% | 1.5 | 30,600 | Common Stock |
| Pulse Biosciences Inc | Kevin P. Danahy | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 21.45 per share. | 09 Feb 2026 | 20,000 | 43,298 (0%) | 0% | 21.5 | 429,000 | Common Stock |
| Pulse Biosciences Inc | Kevin P. Danahy | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.53 per share. | 09 Feb 2026 | 20,000 | 63,298 (0%) | 0% | 1.5 | 30,600 | Common Stock |
| Pulse Biosciences Inc | Kevin P. Danahy | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 23.52 per share. | 09 Feb 2026 | 20,000 | 43,298 (0%) | 0% | 23.5 | 470,400 | Common Stock |
| Pulse Biosciences Inc | Kevin P. Danahy | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.53 per share. | 09 Feb 2026 | 20,000 | 63,298 (0%) | 0% | 1.5 | 30,600 | Common Stock |
| Pulse Biosciences Inc | Kevin P. Danahy | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 25.20 per share. | 09 Feb 2026 | 20,000 | 43,298 (0%) | 0% | 25.2 | 504,000 | Common Stock |
| Bankwell Fin Grp Inc | Kevin D. Leitao | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2026 | 1,455 | 1,455 (0%) | 0% | 0 | Common Stock | |
| RTX | Kevin G. DaSilva | Senior VP and Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2026 | 3,941 | 33,945 (0%) | 0% | 0 | Common Stock | |
| RTX | Kevin G. DaSilva | Senior VP and Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2026 | 3,941 | 7,870 | - | - | Restricted Stock Units | |
| RTX | Kevin G. DaSilva | Senior VP and Treasurer | Grant, award, or other acquisition of securities at price $ 198.66 per share. | 08 Feb 2026 | 3,366 | 37,311 (0%) | 0% | 198.7 | 668,690 | Common Stock |
| RTX | Kevin G. DaSilva | Senior VP and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 198.66 per share. | 08 Feb 2026 | 1,065 | 35,238 (0%) | 0% | 198.7 | 211,573 | Common Stock |
| RTX | Kevin G. DaSilva | Senior VP and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 198.66 per share. | 08 Feb 2026 | 955 | 36,303 (0%) | 0% | 198.7 | 189,720 | Common Stock |
| RTX | Kevin G. DaSilva | Senior VP and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 202.25 per share. | 08 Feb 2026 | 52 | 37,258 (0%) | 0% | 202.3 | 10,517 | Common Stock |
| PACCAR | Kevin D. Baney | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2026 | 26,086 | 26,086 | - | - | Stock Option | |
| PACCAR | Kevin D. Baney | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2026 | 6,944 | 10,243 | - | - | Stock Units (LTIP) | |
| Lee Enterprises Inc | Kevin D. Mowbray | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2026 | 16,374 | 16,374 | - | - | Performance Rights | |
| Lee Enterprises Inc | Kevin D. Mowbray | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2026 | 13,380 | 13,380 | - | - | Employee Stock Option (Right to Buy) | |
| Lee Enterprises Inc | Kevin D. Mowbray | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.46 per share. | 05 Feb 2026 | 7,867 | 118,970 (0%) | 0% | 5.5 | 42,954 | Common Stock |
| PACCAR | Kevin D. Baney | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2026 | 9,672 | 0 | - | - | Stock Option | |
| PACCAR | Kevin D. Baney | Executive Vice President | Sale of securities on an exchange or to another person at price $ 126.53 per share. | 03 Feb 2026 | 9,672 | 12,592 (0%) | 0% | 126.5 | 1,223,803 | Common Stock |
| PACCAR | Kevin D. Baney | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 50.79 per share. | 03 Feb 2026 | 9,672 | 22,264 (0%) | 0% | 50.8 | 491,209 | Common Stock |
| Brinker Intl Inc | Kevin D. Hochman | Director, Pres. & CEO | Sale of securities on an exchange or to another person at price $ 160.31 per share. | 29 Jan 2026 | 66,000 | 129,824 (0%) | 0% | 160.3 | 10,580,460 | Common Stock |
| Brinker Intl Inc | Kevin D. Hochman | Director, Pres. & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 29 Jan 2026 | 2,000 | 195,824 (0%) | 0% | 0 | Common Stock | |
| Republic Bancorp Inc KY | Kevin Sipes D. | EVP & CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 2,873 | 2,873 | - | - | Employee Stock Option (right to buy) | |
| Republic Bancorp Inc KY | Kevin Sipes D. | EVP & CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 525 | 75,232 (0%) | 0% | 0 | Class A Common Stock | |
| Home Bancshares Inc | Kevin D. Hester | President and CLO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2026 | 30,000 | 105,000 (0%) | 0% | 0 | Common Stock - Restricted Stock | |
| Charter (Class A) | Kevin D. Howard | EVP/CAO/Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2026 | 6,131 | 0 | - | - | Stock Options | |
| Charter (Class A) | Kevin D. Howard | EVP/CAO/Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 183.87 per share. | 15 Jan 2026 | 6,131 | 6,363 (0%) | 0% | 183.9 | 1,127,307 | Class A Common Stock |
| Charter (Class A) | Kevin D. Howard | EVP/CAO/Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 194.61 per share. | 15 Jan 2026 | 5,909 | 454 (0%) | 0% | 194.6 | 1,149,950 | Class A Common Stock |
| Charter (Class A) | Kevin D. Howard | EVP/CAO/Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2026 | 1,334 | 1,334 | - | - | Stock Options | |
| Charter (Class A) | Kevin D. Howard | EVP/CAO/Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2026 | 387 | 0 | - | - | Restricted Stock Units | |
| Charter (Class A) | Kevin D. Howard | EVP/CAO/Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2026 | 387 | 841 (0%) | 0% | - | Class A Common Stock | |
| Charter (Class A) | Kevin D. Howard | EVP/CAO/Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 191.77 per share. | 15 Jan 2026 | 104 | 737 (0%) | 0% | 191.8 | 19,944 | Class A Common Stock |
| PACCAR | Kevin D. Baney | Executive Vice President | Other type of transaction at price $ 116.68 per share. | 07 Jan 2026 | 69 | 5,889 (0%) | 0% | 116.7 | 8,051 | Common Stock |
| Definitive Healthcare Corp (Class A) | Kevin D. Coop | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.87 per share. | 01 Jan 2026 | 28,236 | 3,556,552 | - | 2.9 | 81,037 | Class A Common Stock |
| Renasant Corp | Kevin D. Chapman | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2026 | 24,018 | 189,052 (0%) | 0% | 0 | Common Stock | |
| Renasant Corp | Kevin D. Chapman | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2026 | 24,018 | 213,070 (0%) | 0% | 0 | Common Stock | |
| PACCAR | Kevin Baney D. | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2026 | 3,143 | 13,435 (0%) | 0% | 0 | Common Stock | |
| PACCAR | Baney D. Kevin | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2026 | 3,143 | 3,299 | - | - | Stock Units (LTIP) | |
| PACCAR | Baney Kevin D. | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 109.51 per share. | 01 Jan 2026 | 843 | 12,592 (0%) | 0% | 109.5 | 92,317 | Common Stock |
| First Merchants Corp | Kevin D. Johnson | Director | Grant, award, or other acquisition of securities at price $ 37.48 per share. | 31 Dec 2025 | 583 | 8,410 (0%) | 0% | 37.5 | 21,851 | Common |
| PPG Industries | Kevin D. Braun | Sr VP, Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 26 | 824 | - | - | Phantom Stock Units | |
| Galectin Therapeutics Inc | Kevin D. Freeman | Director | Purchase of securities on an exchange or from another person at price $ 3.55 per share. | 23 Dec 2025 | 5,500 | 55,269 (0%) | 0% | 3.5 | 19,514 | Common Stock |
| Galectin Therapeutics Inc | Kevin D. Freeman | Director | Purchase of securities on an exchange or from another person at price $ 3.55 per share. | 23 Dec 2025 | 5,500 | 55,269 (0%) | 0% | 3.5 | 19,514 | Common Stock |
| PPG Industries | Kevin D. Braun | Sr VP, Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2025 | 20 | 798 | - | - | Phantom Stock Units | |
| PPG Industries | Kevin D. Braun | Sr VP, Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 4 | 777 | - | - | Phantom Stock Units | |
| PACCAR | Kevin D. Baney | Executive Vice President | Other type of transaction at price $ 114.24 per share. | 03 Dec 2025 | 17 | 5,808 (0%) | 0% | 114.2 | 1,942 | Common Stock |
| PPG Industries | Kevin D. Braun | Sr VP, Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Nov 2025 | 26 | 773 | - | - | Phantom Stock Units | |
| PPG Industries | Kevin D. Braun | Sr VP, Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Nov 2025 | 21 | 746 | - | - | Phantom Stock Units | |
| First Business Fin Services Inc | Kevin D. Crampton | Chief Accounting Officer | Purchase of securities on an exchange or from another person at price $ 51.39 per share. | 07 Nov 2025 | 71 | 1,892 (0%) | 0% | 51.4 | 3,649 | Common Stock |
| Hayward Holdings Inc | Kevin D. Brown | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 7,550 | 3,208,079 | - | 0 | Common Stock | |
| PPG Industries | Kevin D. Braun | Sr VP, Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2025 | 22 | 697 | - | - | Phantom Stock Units | |
| Pulse Biosciences Inc | Kevin P. Danahy | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Oct 2025 | 4,600 | 425,000 | - | - | Stock Option (right to buy) |